428 related articles for article (PubMed ID: 33874685)
1. [Causes of death and influencing factors of atrial fibrillation patients undergoing anticoagulation therapy].
Hua C; Jiang C; He L; Jia ZX; Lyu WH; Tang RB; Sang CH; Long DY; Dong JZ; Ma CS; Du X
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):353-359. PubMed ID: 33874685
[No Abstract] [Full Text] [Related]
2. Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.
Fauchier L; Villejoubert O; Clementy N; Bernard A; Pierre B; Angoulvant D; Ivanes F; Babuty D; Lip GY
Am J Med; 2016 Dec; 129(12):1278-1287. PubMed ID: 27476087
[TBL] [Abstract][Full Text] [Related]
3. Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.
Pokorney SD; Piccini JP; Stevens SR; Patel MR; Pieper KS; Halperin JL; Breithardt G; Singer DE; Hankey GJ; Hacke W; Becker RC; Berkowitz SD; Nessel CC; Mahaffey KW; Fox KA; Califf RM; ;
J Am Heart Assoc; 2016 Mar; 5(3):e002197. PubMed ID: 26955859
[TBL] [Abstract][Full Text] [Related]
4. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA-AF Registry.
Ding WY; Lane DA; Gupta D; Huisman MV; Lip GYH;
J Am Heart Assoc; 2022 Aug; 11(15):e026410. PubMed ID: 35876418
[TBL] [Abstract][Full Text] [Related]
6. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and hypertrophic cardiomyopathy].
Liu YY; Du X; He L; Hu R; Ning M; Lyu J; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jan; 50(1):62-67. PubMed ID: 35045616
[No Abstract] [Full Text] [Related]
8. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
[TBL] [Abstract][Full Text] [Related]
9. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
[TBL] [Abstract][Full Text] [Related]
10. Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
Pastori D; Pignatelli P; Saliola M; Carnevale R; Vicario T; Del Ben M; Cangemi R; Barillà F; Lip GY; Violi F
Int J Cardiol; 2015 Dec; 201():513-6. PubMed ID: 26318513
[TBL] [Abstract][Full Text] [Related]
11. Association of New-Onset Atrial Fibrillation After Noncardiac Surgery With Subsequent Stroke and Transient Ischemic Attack.
Siontis KC; Gersh BJ; Weston SA; Jiang R; Kashou AH; Roger VL; Noseworthy PA; Chamberlain AM
JAMA; 2020 Sep; 324(9):871-878. PubMed ID: 32870297
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors Associated With Ischemic Stroke in Japanese Patients With Nonvalvular Atrial Fibrillation.
Okumura K; Tomita H; Nakai M; Kodani E; Akao M; Suzuki S; Hayashi K; Sawano M; Goya M; Yamashita T; Fukuda K; Ogawa H; Tsuda T; Isobe M; Toyoda K; Miyamoto Y; Miyata H; Okamura T; Sasahara Y;
JAMA Netw Open; 2020 Apr; 3(4):e202881. PubMed ID: 32293685
[TBL] [Abstract][Full Text] [Related]
13. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B
JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
15. Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study.
Dong Z; Du X; Lu S; Jiang C; Xia S; He L; Su X; Jia Z; Long D; Sang C; Tang R; Liu N; Bai R; Yu R; Dong J; Ma C
BMC Cardiovasc Disord; 2021 Mar; 21(1):146. PubMed ID: 33740910
[TBL] [Abstract][Full Text] [Related]
16. [Association between duration of digoxin use and adverse outcomes among Chinese patients with atrial fibrillation].
Chang SS; Gao Y; Xia SJ; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):728-734. PubMed ID: 32957754
[No Abstract] [Full Text] [Related]
17. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients.
Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
Thromb Haemost; 2017 Jun; 117(7):1448-1454. PubMed ID: 28331926
[TBL] [Abstract][Full Text] [Related]
18. Causes of Death in Anticoagulated Patients With Atrial Fibrillation.
Gómez-Outes A; Lagunar-Ruíz J; Terleira-Fernández AI; Calvo-Rojas G; Suárez-Gea ML; Vargas-Castrillón E
J Am Coll Cardiol; 2016 Dec; 68(23):2508-2521. PubMed ID: 27931607
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK;
Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621
[TBL] [Abstract][Full Text] [Related]
20. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
Hsu JC; Huang YT; Lin LY
Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
